H1 FY15 Results Presentation

Similar documents
For personal use only

For personal use only

Investor Presentation

Contango Asset Management Limited AGM Investor Presentation Marty Switzer CEO and Managing Director

2. Managing Director s Review 3. Ordinary Resolutions 4. Question & Answer Time

For personal use only

For personal use only

For personal use only

Annual Report Foundations for growth

Shine Corporate Ltd 2018 Full Year Results

For personal use only

SAI Global Limited ASX:SAI. SAI Global Limited JP MORGAN EMERGING COMPANIES CONFERENCE APRIL ASX Code: SAI. SAI Global Limited

For personal use only

For personal use only

Presentation by Dr Andrew Blattman to the Goldman Sachs Emerging Leaders Conference 2019

2011 Interim Results. Keith Gordon, Managing Director & Chief Executive Officer Stephen Gobby, Chief Financial Officer

FY18 Results Presentation Bravura Solutions Limited. 28 August 2018

Interim FY 2015 results 6 months ended 31 December February 2015

2018 Full Year Results Investor Presentation

For personal use only

Ramsay Health Care Christopher Rex, Managing Director. Australia and New Zealand 7th Annual Investment Conference London 9 March, 2010

For personal use only. F Y R e s u l t s P r e s e n t a t i o n

Sigma Pharmaceuticals Limited

For personal use only

FY18 FULL YEAR RESULTS REVENUE UP 18%, NPAT UP 43%, FREE CASH FLOW UP 87% FINAL DIVIDEND UP 27%

SLATER & GORDON LIMITED (SGH)

BROKER PRESENTATION JUNE 2017

INVESTOR PRESENTATION

Litigation Capital Management Limited 2018 Half Year Results Presentation Investor Roadshow

PMP LIMITED INVESTOR PRESENTATION. Results for the 12 months ended 30 June August Peter George, CEO Geoff Stephenson, CFO

For personal use only

ASX Media Release WORLEYPARSONS LIMITED (ASX: WOR) FULL YEAR 2017 RESULT

Capital raising. May Doug Rathbone Managing Director and Chief Executive Officer. Kevin Martin Chief Financial Officer

Financial Highlights (1)

FY17 RESULTS. Tuesday 20 February 2018

SFG Australia & IOOF enter into Scheme Implementation Agreement

Full Year Results to 31 January 2018 Announced 22 March 2018

FIRST HALF FINANCIAL YEAR 2018 RESULTS PRESENTATION

Sirtex Medical Limited Results for the full year ended 30 June 2017

Half Year Results to 31 July 2018 Announced 6 September 2018

LIFE STARTS HERE. FY18 Full Year Results Presentation. 27 August 2018

ASX: DDR FY16 Results Presentation. March 2017

FY2018 Half Year Results Presentation 1 March 2018

Ainsworth Game Technology Limited

2017 INVESTOR PRESENTATION SEPTEMBER 2017

AGM Presentation November 2016

For personal use only

ANNUAL GENERAL MEETING

Inghams Group Limited. FY2018 Results Presentation

For personal use only. Acquisition of the icash Australian ATM Operations

Full Year 2017 Results Presentation Bravura Solutions Limited

For personal use only

PMP LIMITED. For personal use only INVESTOR PRESENTATION. Results for the 6 months ended 31 December February 2016

(RBD) INVESTOR PRESENTATION

For personal use only

Coal & renewables in the energy transition

An Integrated Financial Services Company

23 September Australian Securities Exchange Attention: Companies Department BY ELECTRONIC LODGEMENT. Dear Sir/Madam,

Freedom Insurance (FIG)

13 APRIL WestConnex M4 East, New South Wales. Refer to ASX/Media Release for further information

Full Year Results Presentation (ASX Code: HIT) 31 AUGUST 2018

17 April Genex Power s Kidston Solar Farm, Queensland, UGL. Refer to ASX/Media Release for further information

2018 ANNUAL GENERAL MEETING

Interim Results Presentation

BABCOCK & BROWN COMMUNITIES (BBC) CHAIRMAN S ADDRESS

For personal use only

Monash IVF Group. FY16 Results Presentation 26 August 2016

For personal use only

For personal use only

FY16 AGM Presentation

Please find attached ThinkSmart s presentation delivered today at the Micro Equities Microcap Conference held in Sydney.

For personal use only

For personal use only

HUON AQUACULTURE GROUP LIMITED

ANNUAL GENER AL MEETING 2016

For personal use only

A SHORT SMARTPAY. ASX Small / Mid Cap Conference. 6 September Presented by: Bradley Gerdis. September 8 th 2015


Genworth Mortgage Insurance Australia

For personal use only

For personal use only

FINANCIAL RESULTS PRESENTATION H1FY18

For personal use only ANNUAL GENERAL MEETING CEO PRESENTATION 21 NOVEMBER 2017

FY17 Annual Results Announcement

For personal use only

1H 19 Investor Presentation February 2019

EBOS Group Ltd. For personal use only. Results presentation Financial Year ended 30 June August 2016

MOTORCYCLE HOLDINGS LIMITED

For personal use only

Sample. Virtus Health Ltd. Financial Analysis VRT $7.15. No Holding at Time of Report

For personal use only

Ingenia announces sell-down of the Group s DMF portfolio

Doug Rowe CMA Corporation Limited

23 March Australian Securities Exchange Attention: Companies Department BY ELECTRONIC LODGEMENT. Dear Sir / Madam

For personal use only

INSURANCE AUSTRALIA GROUP LIMITED ( IAG ) Presentation to UBS FIG Conference Sydney 22 June 2005

FINANCIAL RESULTS PRESENTATION FY2018

For personal use only

JustKapital s Acquisition of Macquarie Medico Legal & Radiology ( MML ) November 2015

VIRTUS HEALTH (ASX: VRT) FINANCIAL RESULTS PRESENTATION FY2017

Transcription:

H1 FY15 Results Presentation 10 February 2015 Andrew Grech Group Managing Director Wayne Brown CFO Ken Fowlie CEO Australia 1

Disclaimer This document has been prepared by Slater and Gordon Limited (Slater and Gordon) and comprises written materials/slides for a presentation concerning Slater and Gordon. This presentation is for information purposes only and does not constitute or form part of any offer or invitation to acquire, sell or otherwise dispose of, or issue, or any solicitation of any offer to sell or otherwise dispose of, purchase or subscribe for, any securities, nor does it constitute investment advice, nor shall it or any part of it nor the fact of its distribution form the basis of, or be relied on in connection with, any contract or investment decision. Certain statements in this presentation are forward looking statements. You can identify these statements by the fact that they use words such as anticipate, estimate, expect, project, intend, plan, believe, target, may, assume and words of similar import. These forward looking statements speak only as at the date of this presentation. These statements are based on current expectations and beliefs and, by their nature, are subject to a number of known and unknown risks and uncertainties that could cause the actual results, performances and achievements to differ materially from any expected future results, performance or achievements expressed or implied by such forward looking statements. No representation, warranty or assurance (express or implied) is given or made by Slater and Gordon that the forward looking statements contained in this presentation are accurate, complete, reliable or adequate or that they will be achieved or prove to be correct. Except for any statutory liability which cannot be excluded, Slater and Gordon and its respective officers, employees and advisers expressly disclaim any responsibility for the accuracy or completeness of the forward looking statements and exclude all liability whatsoever (including negligence) for any direct or indirect loss or damage which may be suffered by any person as a consequence of any information in this presentation or any error or omission therefrom. Subject to any continuing obligation under applicable law or any relevant listing rules of the ASX, Slater and Gordon disclaims any obligation or undertaking to disseminate any updates or revisions to any forward looking statements in these materials to reflect any change in expectations in relation to any forward looking statements or any change in events, conditions or circumstances on which any statement is based. Nothing in these materials shall under any circumstances create an implication that there has been no change in the affairs of Slater and Gordon since the date of this presentation. 2

H1 FY15: Highlights On track to deliver full year guidance Group revenue up 37.6% to A$245.3m Normalised EBITDA margin 1 of 23.9% Cash flow from operations 78.6% of NPAT Australian Personal Injury Law (PIL) practice remains very resilient UK business performing in line with expectations Continued investment in Slater and Gordon brand Completed acquisitions of Nowicki Carbone and Schultz Toomey O Brien and today announced two further UK acquisitions 3 1. Normalised for acquisition costs of A$1.5m and early termination of property lease of A$1.5m.

H1 FY15: Financial Results H1 FY15 A$M H1 FY14 A$M A$M CHANGE % CHANGE REVENUE 245.3 178.3 67.0 37.6% EBITDA (NORMALISED) 1 58.5 41.0 17.5 42.7% EBITDA MARGIN (NORMALISED) 1 23.9% 23.1% NPAT (NORMALISED) 1 35.9 24.5 11.4 46.5% OPERATING CASH FLOW % NPAT 78.6% 91.5% CENTS CENTS CENTS CHANGE % CHANGE BASIC EPS (NORMALISED) 1 17.5 12.3 5.2 42.3% DILUTED EPS (NORMALISED) 1 17.4 12.1 5.3 43.8% DIVIDEND 3.5 3.0 0.5 16.7% 4 1. FY15 normalised for acquisition costs of A$1.5m and early termination of property lease of A$1.5m. FY14 normalised for acquisition costs of A$2.2m.

EBITDA Bridge 5 1. FY15 normalised for acquisition costs of A$1.5m and early termination of property lease of A$1.5m and FY14 normalised for acquisition costs of A$2.2m. 2. Personal Injury Law (PIL), General Law (GL)

Australian Operations H1 FY15 A$M H1 FY14 A$M A$M CHANGE % CHANGE REVENUE 127.7 116.9 10.8 9.2% EBITDA (NORMALISED) 1 30.6 27.1 3.5 12.9% EBITDA MARGIN (NORMALISED) 1 24.0% 23.4% Commentary Personal Injury Law + Continued strong performance in Victoria + Meeting expectations in NSW, ACT, SA and WA + Queensland remains area of focus + PIL growth opportunities remain General Law + GL on track to deliver targets + Family Law service line well established + Conveyancing now running a single national platform + Business & Specialised Litigation Services recovering after a year of adjustment in FY14 6 1. FY15 normalised for acquisition costs and early termination of property lease.

UK Operations H1 FY15 A$M H1 FY14 A$M A$M CHANGE % CHANGE REVENUE 117.6 61.4 56.2 91.5% EBITDA (NORMALISED) 1 28.0 13.9 14.1 101.4% EBITDA MARGIN (NORMALISED) 1 23.8% 22.6% Commentary Personal Injury Law + Core PIL business delivering solid revenue growth + Acquisitions performing in line with expectations + Legislative environment remains stable + Claims Management Companies continue to consolidate General Law + Increasing depth of competence across key General Law practice groups + Continuing to scale up practices 7 1. FY15 and FY14 normalised for acquisition costs.

UK Acquisitions Overview Walker Smith Way Consumer law firm in North Wales and North West England, with approximately 70% being personal injury Four offices transferring, providing full coverage of North West England and Wales Forecast acquired annual revenue of 10.3m. Proposed completion April 2015 Leo Abse & Cohen Consumer and Specialist PI firm in Cardiff, Wales Expertise in hearing loss claims (UK wide practice) Forecast acquired annual revenue of 8.4m Proposed completion May 2015 8

Impact of UK Acquisitions Annualised Revenue M Annualised Revenue A$M 1 FY15 Pro Rata Revenue M FY15 Pro Rata Revenue A$M 1 Completion Date Walker Smith Way 10.3 $19.1 2.6 $4.8 April 2015 Leo Abse & Cohen 8.4 $15.6 1.4 $2.6 May 2015 Total 18.7 $34.7 4.0 $7.4 + Total consideration for both acquisitions 18.7m, consisting of: + 10.4m cash at completion (including extinguishment of debt) + 3.7m of equity consideration + 4.6m of deferred and conditional consideration over two years post completion + Average EBITDA acquisition multiple of 4.2x 9 1. Assumes GBP:AUD exchange rate of 0.54.

Outlook for FY15 Confirmed + Group revenue target of A$500m 1, 2 + Normalised EBITDA margin of 23% 24% + Cash flow from Operations as a % of NPAT >70% FY15 12% UK PI Law UK General Law Aus PI Law Aus General Law 43% 12% 33% 10 1. Includes contribution of A$25.6m from Australian acquisitions completed in H1 but excludes proposed UK acquisitions announced today. 2. Assumes GBP:AUD exchange rate of 0.54.

Appendix 1: H1 FY15 Results (AUS & UK) AUST A$M UK A$M 1 H1 FY15 A$M H1 FY14 A$M A$M CHANGE % CHANGE REVENUE 127.7 117.6 245.3 178.3 67.0 37.6% EBITDA 28.4 27.0 55.4 38.8 16.6 42.8% EBITDA MARGIN 22.3% 23.0% 22.6% 21.9% EBIT 25.8 25.2 51.0 35.2 15.8 44.9% EBIT MARGIN 20.3% 21.5% 20.8% 19.8% NPAT 15.2 18.5 33.7 23.0 10.7 46.5% NPAT MARGIN 11.9% 15.7% 13.7% 12.9% CENTS CENTS CENTS CHANGE % CHANGE BASIC EPS 16.5 11.5 5.0 43.5% DILUTED EPS 16.3 11.3 5.0 44.2% DIVIDEND 3.5 3.0 0.5 16.7% 11 1. Actual average exchange rate for H1FY15 of 0.5471.

Appendix 2: Balance Sheet BALANCE SHEET (GROUP) H1 FY15 FY14 DEBTOR DAYS 1 88 92 PAID DISBURSEMENT DAYS 1 41 43 WIP DAYS (AUSTRALIA) 2 447 441 WIP DAYS (UK) 2 302 304 NET BANK DEBT/EQUITY 34.4% 23.9% INTEREST COVER (TIMES) 3 16.0 17.0 RETURN ON EQUITY 14.8% 15.2% 12 1. Based on net fees. 2. Based on total revenue. 3. Interest cover excludes notional interest on deferred consideration.

13